Announcement from Acarix’s extra general meeting
The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 28 September 2023 and the following resolution was...
Acarix expands use of CADScor System into Osteopathic Medicine
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces expanded utilization of the CADScor® System into the...
Acarix changes Certified Adviser to Penser Bank AB
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser.Acarix AB has entered into...
Notice of Extra General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Th...
Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix receives initial order from the emerging East African market
Acarix, a leader in acoustic and AI-based cardiac diagnostics, partners with Maeva Health, led by Dr. Peter Svalander, CEO, to launch t...
Acarix AB (publ) publishes Interim Report, April – June 2023
Traction in the US market reflects transition to a new expanded commercial modelIn 2022, we initiated the transition of Acarix to full ...
Invitation to presentation of Acarix´s second quarter earnings report
Acarix, a leader in acoustic and AI-based cardiac diagnostics, will publish its second quarter results on Thursday 31 August 2023 08:00...
First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a significant advancement in the utilization of its CADS...
Acarix welcomes Dr. Deepak R. Talreja MD as new Medical Advisor
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of Dr. Deepak R. Talreja, MD, as new Med...
Acarix to participate in Erik Penser Bank’s Company Day on August 24, 2023
Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce participation in the upcoming Erik Penser Bank Co...
Announcement from Acarix’s extra general meeting
The extra general meeting of Acarix AB (the "Company") was held today on 9 June 2023 and the following resolutions were passed by the m...